GBM Lunch
Matthias Peipp: Novel Strategies in Improving Effector Cell Activation in Antibody-Based Immunotherapy
01.12.2021
12:30-13:30
Speaker: Matthias Peipp, Research Head & Mildred Scheel Professor, Stem Cell Transplantation & Immunotherapy, University of Kiel
Chair: Stefan Zielonka, Protein Engineering & Antibody Technologies, Merck KGaA, Darmstadt
Organizers: Study Group Protein Engineering and Design